Journal of Clinical Virology
Volume 40, Issue 2 , Pages 129-134 , October 2007

Detection and differentiation of wild-type and vaccine mutant varicella-zoster viruses using an Invader Plus® method

  • Yi-Wei Tang

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, United States
    • Department of Pathology, Vanderbilt University School of Medicine, Nashville, TN 37232, United States
    • Corresponding Author InformationCorresponding author at: Molecular Infectious Diseases Laboratory, 4605 TVC, Vanderbilt University Hospital, Tennessee 37232-5310, United States. Tel.: +1 615 322 2035; fax: +1 615 343 8420.
    • ,
  • Hatim T. Allawi

      Affiliations

    • Third Wave Technologies, Inc., Madison, WI 53719, United States
    • ,
  • Marlene DeLeon-Carnes

      Affiliations

    • National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, United States
    • ,
  • Haijing Li

      Affiliations

    • Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, United States
    • ,
  • Stephen P. Day

      Affiliations

    • Third Wave Technologies, Inc., Madison, WI 53719, United States
    • ,
  • D. Scott Schmid

      Affiliations

    • National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, United States

Received 16 March 2007 ,Revised 13 July 2007 ,Accepted 18 July 2007.

References 

  1. Allawi HT, Li HJ, Aslanukov A, Hall J, Lyamichev VI, Blackman A, et al. Invader Plus assay detects herpes simplex virus in cerebrospinal fluid and simultaneously differentiates types 1 and 2. J Clin Microbiol. 2006;44(9):3443–3447
  2. Campsall PA, Au NH, Prendiville JS, Speert DP, Tan R, Thomas EE. Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR. J Clin Microbiol. 2004;42(4):1409–1413
  3. Dahl H, Marcoccia J, Linde A. Antigen detection: the method of choice in comparison with virus isolation and serology for laboratory diagnosis of herpes zoster in human immunodeficiency virus-infected patients. J Clin Microbiol. 1997;35(2):347–349
  4. Espy MJ, Teo R, Ross TK, Svien KA, Wold AD, Uhl JR, et al. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38(9):3187–3189
  5. Gershon AA, Steinberg SP, Gelb L. Live attenuated varicella vaccine use in immunocompromised children and adults. Pediatrics. 1986;78(4 Pt 2):757–762
  6. Gnann JW, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med. 2002;347(5):340–346
  7. Kaiser MW, Lyamicheva N, Ma W, Miller C, Neri B, Fors L, et al. A comparison of eubacterial and archaeal structure-specific 5′-exonucleases. J Biol Chem. 1999;274(30):21387–21394
  8. Kido S, Ozaki T, Asada H, Higashi K, Kondo K, Hayakawa Y, et al. Detection of varicella-zoster virus (VZV) DNA in clinical samples from patients with VZV by the polymerase chain reaction. J Clin Microbiol. 1991;29(1):76–79
  9. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992;66(2):1016–1020
  10. Loparev VN, McCaustland K, Holloway BP, Krause PR, Takayama M, Schmid DS. Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J Clin Microbiol. 2000;38(12):4315–4319
  11. Lyamichev V, Mast AL, Hall JG, Prudent JR, Kaiser MW, Takova T, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol. 1999;17(3):292–296
  12. Lyamichev VI, Kaiser MW, Lyamicheva NE, Vologodskii AV, Hall JG, Ma WP, et al. Experimental and theoretical analysis of the invasive signal amplification reaction. Biochemistry. 2000;39(31):9523–9532
  13. McCarter YS, Ratkiewicz IN. Comparison of virus culture and direct immunofluorescent staining of cytocentrifuged virus transport medium for detection of varicella-zoster virus in skin lesions. Am J Clin Pathol. 1998;109(5):631–633
  14. Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–2284
  15. Puchhammer-Stockl E, Popow-Kraupp T, Heinz FX, Mandl CW, Kunz C. Establishment of PCR for the early diagnosis of herpes simplex encephalitis. J Med Virol. 1990;32(2):77–82
  16. Sauerbrei A, Eichhorn U, Schacke M, Wutzler P. Laboratory diagnosis of herpes zoster. J Clin Virol. 1999;14(1):31–36
  17. Sefers SE, Rickmyre J, Blackman A, Li H, Edwards K, Tang YW. QIAamp MinElute virus kit effectively extracts viral nucleic acids from cerebrospinal fluids and nasopharyngeal swabs. J Clin Virol. 2006;35(2):141–146
  18. Takahashi M, Otsuka T, Okuno Y, Asano Y, Yazaki T. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet. 1974;2(7892):1288–1290
  19. Takayama M, Takayama N. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF 6-based PCR and restriction fragment length polymorphism analysis. J Clin Virol. 2004;29(2):113–119
  20. Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, Graham BS, et al. Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol. 2003;41(6):2633–2640
  21. Tipples GA, Safronetz D, Gray M. A real-time PCR assay for the detection of varicella-zoster virus DNA and differentiation of vaccine, wild-type and control strains. J Virol Meth. 2003;113(2):113–116
  22. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol. 2003;41(2):576–580
  23. Weidmann M, Meyer-Konig U, Hufert FT. Rapid detection of herpes simplex virus and varicella-zoster virus infections by real-time PCR. J Clin Microbiol. 2003;41(4):1565–1568
  24. White CJ. Varicella-zoster virus vaccine. Clin Infect Dis. 1997;24(5):753–761quiz 762–3

☆ The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the funding agencies.

PII: S1386-6532(07)00256-9

doi: 10.1016/j.jcv.2007.07.007

Journal of Clinical Virology
Volume 40, Issue 2 , Pages 129-134 , October 2007

Article Tools